Aller au contenu principal
ProhibitedBinding ruleBROfficial English translationImport de la source officielle contrôlé

Pirofosfato de Tetraetila

ANVISA lists this substance among materials that may not be used in personal-hygiene products, cosmetics or perfumes in Brazil.

Décision réglementaire et conditions complètes

Statut
Prohibited
Rôle juridique
Binding rule
Résumé réglementaire
ANVISA lists this substance among materials that may not be used in personal-hygiene products, cosmetics or perfumes in Brazil.
Conditions et restrictions

Pirofosfato de Tetraetila

Identité de la substance

Nom dans la source officielle
Pirofosfato de Tetraetila
CAS
107-49-3
EC
203-495-3
Correspondance d’identité
standalone:official_anvisa_record

Aperçu multi-marchés pour cette identité

Fiches exactes associées actuellement présentes sur ce site. L’absence d’un marché signifie qu’aucune correspondance exacte n’a été importée, et non une autorisation d’utiliser la substance.

10 jeux de données de marchés
Structure chimique 2D PubChem pour le CAS 107-49-3
CAS 107-49-3PubChem CID 7873

Chimie vérifiée pour le CAS 107-49-3

Tetraethyl Pyrophosphate

TEPP is an organic diphosphate. — ChEBI

Nom IUPAC
diethoxyphosphoryl diethyl phosphate
Formule moléculaire
C8H20O7P2
Masse moléculaire
290.19 g/mol
Masse exacte
290.06842697 Da
Masse monoisotopique
290.06842697 Da
XLogP3
0,4
Surface polaire topologique
80,3 Ų
Complexité moléculaire
246,0
Charge formelle
0
Donneurs de liaisons hydrogène
0
Accepteurs de liaisons hydrogène
7
Liaisons rotatives
10
Atomes lourds
17
Unités covalentes
1

Noms et synonymes signalés à PubChem

TEPPTetraethyl diphosphateVapotoneBladanTetronMortopalTetrastigmineHepthexamite
16 autres noms signalés
FosvexGrisolKillaxLirohexNifostNifosKilmite 40HexamiteKillexLethalaire G-52Tetron-100Nifos TDiphosphoric acid, tetraethyl esterEthyl pyrophosphate, tetra-Rcra waste number P111Ethyl pyrophosphate (Et4P2O7)
Identifiants de bases de données externes
Statistiques de structure avancées
Stéréocentres atomiques définis
0
Stéréocentres atomiques non définis
0
Stéréocentres de liaison définis
0
Stéréocentres de liaison non définis
0
Caractéristiques pharmacophoriques 3D
2
Cycles 3D
0
Groupes hydrophobes 3D
0
Caractéristiques d’accepteur 3D
2
Caractéristiques de donneur 3D
0
Centres anioniques 3D
0
Centres cationiques 3D
0
Conformères 3D
10
Rotors 3D effectifs
10,0
Identifiants de structure lisibles par machine
SMILES
CCOP(=O)(OCC)OP(=O)(OCC)OCC
InChI
InChI=1S/C8H20O7P2/c1-5-11-16(9,12-6-2)15-17(10,13-7-3)14-8-4/h5-8H2,1-4H3
InChIKey
IDCBOTIENDVCBQ-UHFFFAOYSA-N

Preuves issues de bases de données scientifiques complémentaires

EMBL-EBI ChEBI
Correspondance exacte d’identifiantCHEBI:82149

TEPP

Formule
C8H20O7P2
Masse moyenne
290.189 g/mol
Masse monoisotopique
290.06843 Da
Charge formelle
0
  • organic diphosphate — is a (CHEBI:62889)
  • organic diphosphate — is a (CHEBI:62889)
Noms supplémentaires validés
ethyl pyrophosphateEthyl pyrophosphateNSC-14707Tetraethyl pyrophosphate
Références croisées de cette source
  • CAS: 107-49-3 — KEGG COMPOUND
  • MANUAL_X_REF: 1272 — PPDB
  • MANUAL_X_REF: C19017 — KEGG COMPOUND

Mis en correspondance par: Exact CAS cross-reference in the ChEBI compound record. Récupéré le: 2026-08-31. Ouvrir la fiche source

NIH PubChem PUG-View
Correspondance exacte d’identifiant7873

Attributed physical-property, hazard, environmental and use annotations.

  • First Aid: Warning: Effects may be delayed up to 12 hours. Caution is advised.; Note: TEPP is a cholinesterase inhibitor.; Signs and Symptoms of TEPP Exposure: Acute exposure to TEPP may produce the following signs and symptoms: sweating, pinpoint pupils, blurred vision, headache, dizziness, profound weakness, muscle spasms, seizures, and coma. Mental confusion and psychosis may occur. Excessive salivation, nausea, vomiting, anorexia, diarrhea, and abdominal pain may also occur. The heart rate may decrease following oral exposure or increase following dermal exposure. Chest pain may be noted. Hypotension (low blood pressure) may be observed, although hypertension (high blood pressure) is not uncommon. Respiratory symptoms include dyspnea (shortness of breath), pulmonary edema, respiratory depression, and respiratory paralysis.; Emergency Life-Support Procedures: Acute exposure to TEPP may require decontamination and life support for the victims. Emergency personnel should wear protective clothing appropriate to the type and degree of contamination. Air purifying or supplied-air respiratory equipment should also be worn, as necessary. Rescue vehicles should carry supplies such as plastic sheet Source: CAMEO Chemicals
  • First Aid: (General first aid procedures); Eye: Irrigate immediately - If this chemical contacts the eyes, immediately wash (irrigate) the eyes with large amounts of water, occasionally lifting the lower and upper lids. Get medical attention immediately.; Skin: Water flush immediately - If this chemical contacts the skin, immediately flush the contaminated skin with water. If this chemical penetrates the clothing, immediately remove the clothing and flush the skin with water. Get medical attention promptly.; Breathing: Respiratory support; Swallow: Medical attention immediately - If this chemical has been swallowed, get medical attention immediately. Source: The National Institute for Occupational Safety and Health (NIOSH)
  • Signal: Danger Source: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • GHS Hazard Statements: H300: Fatal if swallowed [Danger Acute toxicity, oral]; H310: Fatal in contact with skin [Danger Acute toxicity, dermal]; H400: Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard] Source: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • Precautionary Statement Codes: P262, P264, P270, P273, P280, P301+P316, P302+P352, P316, P321, P330, P361+P364, P391, P405, and P501 (click each P-code to see the statement) Source: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • Signal: Danger Source: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H300 (100%): Fatal if swallowed [Danger Acute toxicity, oral]; H310 (100%): Fatal in contact with skin [Danger Acute toxicity, dermal]; H400 (100%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard] Source: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P262, P264, P270, P273, P280, P301+P316, P302+P352, P316, P321, P330, P361+P364, P391, P405, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 42 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
  • Signal: Danger Source: NITE-CMC
  • GHS Hazard Statements: H300: Fatal if swallowed [Danger Acute toxicity, oral]; H310: Fatal in contact with skin [Danger Acute toxicity, dermal]; H315: Causes skin irritation [Warning Skin corrosion/irritation]; H319: Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H330: Fatal if inhaled [Danger Acute toxicity, inhalation]; H370: Causes damage to organs [Danger Specific target organ toxicity, single exposure]; H372: Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure] Source: NITE-CMC
  • Precautionary Statement Codes: P260, P262, P264, P264+P265, P270, P271, P280, P284, P301+P316, P302+P352, P304+P340, P305+P351+P338, P308+P316, P316, P319, P320, P321, P330, P332+P317, P337+P317, P361+P364, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement) Source: NITE-CMC
  • GHS Hazard Statements: H300: Fatal if swallowed [Danger Acute toxicity, oral]; H310: Fatal in contact with skin [Danger Acute toxicity, dermal]; H315: Causes skin irritation [Warning Skin corrosion/irritation]; H319: Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H330: Fatal if inhaled [Danger Acute toxicity, inhalation]; H370: Causes damage to organs [Danger Specific target organ toxicity, single exposure]; H373: May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure] Source: NITE-CMC
  • Signal: Danger Source: Hazardous Chemical Information System (HCIS), Safe Work Australia
  • Environmental Bioconcentration: An estimated BCF of 3.2 was calculated for tetraethyl pyrophosphate(SRC), using an estimated log Kow of 0.45(1) and a regression-derived equation(2). According to a classification scheme(3), this BCF suggests the potential for bioconcentration in aquatic organisms is low(SRC), provided the compound is not altered physically or chemically once released into the environment. Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 2.2(SRC), determined from a water solubility of 1.00X10+6 mg/L(2) and a regression-derived equation(3), indicates that tetraethyl pyrophosphate is expected to have very high mobility in soil(SRC). Volatilization of tetraethyl pyrophosphate from moist soil surfaces is not expected to be an important fate process(SRC) given an estimated Henry's Law constant of 2.2X10-10 atm-cu m/mole(SRC) derived from its vapor pressure, 2.60X10-4 mm Hg at 25 °C(2), and water solubility(2). Tetraethyl pyrophosphate is not expected to volatilize from dry soil surfaces(SRC) based upon its vapor pressure(2). Biodegradation data for this substance were not located in the literature. Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 2.2(SRC), determined from a water solubility of 1.00X10+6 mg/L(2) and a regression-derived equation(3), indicates that tetraethyl pyrophosphate is not expected to adsorb to suspended solids and sediment(SRC). Volatilization from water surfaces is not expected(3) based upon an estimated Henry's Law constant of 2.2X10-10 atm-cu m/mole(SRC), derived from its vapor pressure, 2.60X10-4 mm Hg at 25 °C(2), and water solubility(2). Using this Henry's Law constant and an estimation method(3). According to a classification scheme(4), an estimated BCF of 3.2(SRC), from an estimated log Kow(5) and a regression-derived equation(6), suggests the potential for bioconcentration in aquatic organisms is low(SRC). Biodegradation data for this substance were not located in the literature. Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), tetraethyl pyrophosphate, which has a vapor pressure of 2.60X10-4 mm Hg at 25 °C(2), is expected to exist solely as a vapor in the ambient atmosphere. Vapor-phase tetraethyl pyrophosphate is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 5.0 hours(SRC), calculated from its rate constant of 7.7X10-11 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(3). Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: Aquatic or Terrestrial Fate: ... Rapidly hydrolyzed in the presence of moisture. Source: Hazardous Substances Data Bank (HSDB)

Mis en correspondance par: Existing checksum-valid CAS to unique PubChem CID match. Récupéré le: 2026-08-31. Ouvrir la fiche source

Les classifications scientifiques et les annotations de danger apportent du contexte et ne remplacent pas la décision réglementaire propre au marché indiquée ci-dessus.

Couverture des sources complémentaires et état des correspondances
SourceRésultatVérifié
EMBL-EBI ChEBICorrespondance exacte2026-08-31
NIH PubChem PUG-ViewCorrespondance exacte2026-08-31

Une absence de correspondance enregistrée est une preuve utile que la source a été vérifiée ; ce n’est pas l’affirmation que la substance n’existe pas ailleurs.

Récupéré depuis NIH PubChem le 2026-08-31 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.

Source officielle et provenance

Source enregistrée
Brazil ANVISA consolidated prohibited substances — RDC 529/2021 through RDC 1.030/2026
Référence de la source
RDC 529/2021 consolidated annex, entry 276 (through RDC 1.030/2026)
Identifiant de la fiche source
annex:276
Version de la source
RDC 529/2021 consolidated through RDC 1.030/2026
Langue de la source
Portuguese with official English identity where published
État de la traduction
Official English translation · Traduction anglaise
Date d’effet
2026-06-15
Source mise à jour le
2026-06-15
Instantané vérifié le
2026-08-31 15:26 UTC
Méthode de validation
pdfplumber government baseline + 4 RDC 1.030 exclusions + 15 additions; 1,387 substantive rows
SHA-256
a212e85540a186a842664fbdd4f351af0b1b4baeeb0c4765b9b52c6ce91c1e84

Notes du jeu de données enregistré

Couverture du jeu de données
All 1,387 substantive current prohibited rows after applying RDC 1.030/2026 additions, amendments and exclusions to RDC 529/2021
Note sur l’autorité
Binding consolidated prohibited list for personal-hygiene products, cosmetics and perfumes

Place de cette fiche dans le jeu de données du marché

1387
fiches Brazil actuelles
1387
fiches marquées Prohibited
1387
fiches de cette version de la source
1335
fiches du marché avec identité CAS

Répartition des statuts

Un texte de conditions est présent pour 1387 des 1387 fiches actuelles. Un champ de conditions vide est interprété selon le type de fiche ci-dessus ; il n’est jamais converti en une affirmation d’utilisation sans restriction.

Brazil contexte du marché

Complete prohibited dataset plus current restricted-list workflow

Version de la couverture : ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026

All 1,387 substantive current prohibited rows in RDC 529/2021 consolidated through RDC 1.030/2026, plus the current RDC 1.029 restricted-list and identity workflow.

Liste de contrôle de vérification

  1. Resolve Portuguese, INCI and CAS identity with the ANVISA crosswalk.
  2. Check the consolidated prohibited list including RDC 1.030/2026 changes.
  3. Apply RDC 1.029/2026 restrictions and the still-effective complementary rules.
  4. Verify Mercosur incorporation, regularisation, labelling and transition periods.

Sources officielles du marché

Procédure de vérification et exhaustivité de la fiche

Avant d’utiliser ce résultat dans une décision de conformité

  1. Confirmez que « Pirofosfato de Tetraetila » et chaque identifiant CAS/CE correspondent à la matière de votre spécification fournisseur.
  2. Resolve Portuguese, INCI and CAS identity with the ANVISA crosswalk.
  3. Check the consolidated prohibited list including RDC 1.030/2026 changes.
  4. Apply RDC 1.029/2026 restrictions and the still-effective complementary rules.
  5. Verify Mercosur incorporation, regularisation, labelling and transition periods.
  6. Consignez la version de la source et revérifiez auprès de l’autorité de réglementation avant la fabrication, la notification ou la mise sur le marché.

Champs disponibles dans cette fiche

  • Nom officiel de la substanceDisponible
  • CASDisponible
  • ECDisponible
  • Texte de condition distinctDisponible
  • Date d’effetDisponible
  • Empreinte de l’instantané et méthodeDisponible

Questions auxquelles cette page répond

This official record identifies the substance as prohibited for cosmetic use in the stated market scope. Do not rely on a formulation containing this identity until the cited source, effective date and exact substance match have been verified.

A prohibition entry may contain no separate condition text because the regulatory outcome is the prohibition itself. RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026.

La fiche cite RDC 529/2021 consolidated annex, entry 276 (through RDC 1.030/2026), version de la source RDC 529/2021 consolidated through RDC 1.030/2026. Ouvrir la source officielle.

Non. Le CAS aide à déterminer l’identité, mais les juridictions peuvent classer différemment une même substance et appliquer des champs d’application, limites, avertissements et dates de transition différents.

Citation stable

Pirofosfato de Tetraetila. RDC 529/2021 consolidated annex, entry 276 (through RDC 1.030/2026). Brazil. Source version RDC 529/2021 consolidated through RDC 1.030/2026. CosIng Checker regulatory record: https://cosingchecker.com/fr/regulations/br/records/13482/

Citez l’autorité de réglementation comme autorité juridique. Cette page est un index structuré de preuves et une aide à la vérification, et non un substitut au texte officiel ni à une évaluation juridique professionnelle.

Interprétation et limites pour Brazil

This official record identifies the substance as prohibited for cosmetic use in the stated market scope.

Do not rely on a formulation containing this identity until the cited source, effective date and exact substance match have been verified.

Comment interpréter le rôle juridique

The cited row forms part of a binding rule or legally incorporated list for this market.

Preuves sur cette page

  • Résultat enregistré : Prohibited
  • Rôle juridique : Binding rule
  • Version de la source : RDC 529/2021 consolidated through RDC 1.030/2026
  • Date d’effet : 2026-06-15

Ce que cela ne prouve pas

RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026.

Recherche complémentaire sur la substance auprès de sources faisant autorité

Aucune de ces sources ne prévaut sur la décision de marché ci-dessus.

Cosmetic Ingredient Review safety assessments

Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents

Independent expert review considered by FDA; not a government approval or binding market rule

Rechercher cette identité à la source

FDA Global Substance Registration System

UNII identifiers, preferred names, substance types, codes and public substance relationships

Identity registry only; UNII availability does not imply FDA review or approval

Rechercher cette identité à la source

ILO/WHO International Chemical Safety Cards

Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals

International occupational chemical-safety reference; not cosmetic-use approval

Rechercher cette identité à la source

Japan NITE-CHRIP

Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information

Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules

Rechercher cette identité à la source

NIOSH Pocket Guide to Chemical Hazards

REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals

US occupational-health guidance and limits; not a cosmetic ingredient decision

Rechercher cette identité à la source

OECD eChemPortal

Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records

Discovery gateway; each linked authority remains responsible for its data

Rechercher cette identité à la source

US EPA CompTox CTX APIs

Clé d’API requise pour l’import

DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data

Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality

Rechercher cette identité à la source